|
BUSINESS HEADLINES
|
|
|
 |
|
|
› HNA cuts stake in Deutsche Bank to 6.3 percent: SEC filing
Chinese conglomerate HNA has cut its stake in Deutsche Bank to 6.3 percent, according to a filing with the U.S. Securities and Exchange Commission. |
|
 |
|
› U.S.-China trade talks to resume next week, Trump hints at extension
The United States and China will resume trade talks next week in Washington with time running short to ease their bruising trade war, but U.S. President Donald Trump repeated on Friday that he may extend a March 1 deadline for a deal and keep tariffs on Chinese goods from rising. |
|
|
|
› China-U.S. trade talks 'making a final sprint': state media
Chinese state media on Saturday expressed cautious optimism over trade talks between the United States and China, a day after President Xi Jinping said a week of discussions had produced "step-by-step" progress. |
|
|
|
› Automakers brace for U.S. government report on import tariffs
A confidential Commerce Department report due to be sent to Donald Trump on Sunday is widely expected to clear the way for the U.S. president to threaten tariffs on imported autos and auto parts by designating the imports a national security threat, auto industry officials said on Friday. |
|
|
|
› Payless ShoeSource to start liquidation sales at stores
U.S. discount retailer Payless ShoeSource Inc said on Friday it would begin going-out-of-business sales at its U.S. and Puerto Rico stores on Feb. 17 and wind down its e-commerce operations. |
|
|
|
› Big U.S. exchanges to sue SEC over 'overreaching' fee experiment
The three largest U.S. stock exchange operators said they will sue the Securities and Exchange Commission for overstepping its authority by ordering a pilot program to test banning lucrative payments exchanges make to brokers for resting stock orders. |
|
|
|
› Starboard gauges Bristol-Myers shareholder support for Celgene deal
Activist hedge fund Starboard Value LP has asked a proxy solicitor to probe the level of support among Bristol-Myers Squibb Co shareholders for the U.S. drug maker's $74 billion deal to buy Celgene Corp, people familiar with the matter said on Friday. |
|
|
|
› Mexico to inject $3.9 billion in Pemex, seeks to prevent credit downgrade
Mexico will inject $3.9 billion into ailing state oil company Pemex, officials said on Friday, promising to strengthen its finances and prevent a further credit downgrade, although investors saw the plan as only a short-term fix. |
|
|
|
› Analyst View: Investors divided over Mexico's bailout of state oil company
The Mexican government promised on Friday to do what it takes to strengthen the finances of ailing state oil company Petroleos Mexicanos with an injection of at least $3.6 billion to prevent a further credit downgrade. |
|
|
|
› Mattel warns of weak 2019, shares drop most in 20 years
Mattel Inc on Friday issued a disappointing 2019 forecast and said demand for its iconic Barbie doll was slowing, triggering an 18 percent drop in its shares, their worst day in nearly two decades. |
|
|
|
› Wall Street Week Ahead: Profit estimates may be adding in too much cost risk
As Wall Street braces for the first quarterly decline in earnings in nearly three years, some investors are wondering if the market is factoring in a bigger erosion in profit margins than will actually come to pass. |
|
|
|
› Fed policymakers see one U.S. rate hike, or none, as growth slows
When the Federal Reserve last month adopted a new "patient" approach to monetary policy, it gave no specific guidance about how long its policy pause would last, or how many more interest-rate increases, if any, were in the offing. |
|
|
|
|
|
|
|
|
|
|
| |
